Preclinical pharmacology and toxicology study of Ad-hTERT-E1a-Apoptin, a novel dual cancer-specific oncolytic adenovirus
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference45 articles.
1. Adenoviral gene therapy for cancer: from vectors to targeted and replication competent agents (review);Bauerschmitz;Int. J. Oncol.,2002
2. Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer;Bauerschmitz;Int. J. Cancer,2004
3. Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirus;Bazan-Peregrino;Hum. Gene Ther.,2008
4. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells;Bischoff;Science,1996
5. Adenovirus: a blueprint for non-viral gene delivery;Chailertvanitkul;Curr. Opin. Biotechnol.,2010
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recombinant Oncolytic Adenovirus Combined with Cyclophosphamide Induces Synergy in the Treatment of Breast Cancer in vitro and in vivo;Cancer Management and Research;2022-09
2. Apoptin mediates mitophagy and endogenous apoptosis by regulating the level of ROS in hepatocellular carcinoma;Cell Communication and Signaling;2022-09-01
3. In vivo and in vitro inhibition of SCLC by combining dual cancer-specific recombinant adenovirus with Etoposide;Journal of Cancer Research and Clinical Oncology;2022-01-17
4. Ad-Apoptin-hTERTp-E1a Regulates Autophagy Through the AMPK-mTOR-eIF4F Signaling Axis to Reduce Drug Resistance of MCF-7/ADR Cells;Frontiers in Molecular Biosciences;2021-11-19
5. Suppression effect of a dual cancer-specific oncolytic adenovirus on luciferase-labeled human melanoma cells in vitro and in vivo;Cancer Biomarkers;2021-11-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3